Ken Fisher Zai Lab LTD Transaction History

Fisher Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 05, 2022	SELL	$27.77 - $64.4 $55 - $128	-2 Reduced 0.03%	5,777 $254,000
Q4 2021 Feb 02, 2022	SELL	$54.9 - $105.21 $384 - $736	-7 Reduced 0.12%	5,779 $363,000
Q3 2021 Oct 26, 2021	SELL	$105.0 - $178.37 $545,475 - $926,632	-5,195 Reduced 47.31%	5,786 $610,000
Q2 2021 Jul 27, 2021	SELL	$125.11 - $180.0 $125 - $180	-1 Reduced 0.01%	10,981 $1.94 Million
Q1 2021 Apr 27, 2021	BUY	$126.27 - $191.71 $126 - $191	1 Added 0.01%	10,982 $1.47 Million
Q3 2020 Nov 10, 2020	BUY	$73.3 - $89.48 $804,907 - $982,579	10,981 New	10,981 $913,000

123

46.7M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.55B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Fisher Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fisher Asset Management, LLC and Ken Fisher with notifications on news.